Aspirin as a potential modality for the chemoprevention of breast cancer: A dose-response meta-analysis of cohort studies from 857,831 participants

BACKGROUND: Previous meta-analyses on the relationship between aspirin use and breast cancer risk have drawn inconsistent results. In addition, the threshold effect of different doses, frequencies and durations of aspirin use in preventing breast cancer have yet to be established. RESULTS: The searc...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Liming, Shi, Leiyu, Zeng, Jingchun, Wen, Zehuai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522308/
https://www.ncbi.nlm.nih.gov/pubmed/28418881
http://dx.doi.org/10.18632/oncotarget.16315

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522308/
https://www.ncbi.nlm.nih.gov/pubmed/28418881
http://dx.doi.org/10.18632/oncotarget.16315

Ejemplares similares